p6gag of human and simian immunodeficiency viruses is tolerant to small in-frame deletions downstream of the late domain

Virology

Volumn 346, Issue 2, 2006, Pages 479-489

  Pikora, Cheryl A ^a   Wittish, Christine ^a   Desrosiers, Ronald C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

HIV; LTNP; p6gag; SIV

Indexed keywords

GAG PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL CULTURE; DOWNSTREAM PROCESSING; ENZYME POLYMORPHISM; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTAGENESIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIMIAN VIRUS; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CELLS, CULTURED; GENE PRODUCTS, GAG; HIV CORE PROTEIN P24; HIV-1; HUMANS; LYMPHOCYTES; MACACA MULATTA; MOLECULAR SEQUENCE DATA; MUTAGENESIS; POLYMERASE CHAIN REACTION; SEQUENCE DELETION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ASSEMBLY; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN VIRUS;

EID: 33644823875     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2005.10.040     Document Type: Article

References (29)

1. M.A. Accola, A.A. Bukovsky, M.S. Jones, and H.G. Gottlinger A conserved dileucine-containing motif in p6gag governs the particle association of vpx and vpr of Simian Immunodeficiency Viruses SIVmac and SIVagm J. Virol. 73 1999 9992 9999
2. L.E. Alexander, E. Weiskopf, T.C. Greenough, N.C. Gaddis, M.R. Auerbach, M.H. Malim, S.J. O'Brien, B.D. Walker, J.L. Sullivan, and R.C. Desrosiers Unusual polymorphisms in Human Immunodeficiency Virus Type 1 associated with nonprogressive infection J. Virol. 74 2000 4361 4376
3. F. Bachand, X. Yao, M. Hrimech, N. Rougeau, and E.A. Cohen Incorporation of vpr in Human Immunodeficiency Virus Type 1 requires a direct interaction with the p6 domain of the p55 gag precursor J. Biol. Chem. 274 1999 9083 9091
4. K.A. Barrie, E.E. Perez, S.L. Lamers, W.G. Farmerie, B.M. Dunn, J.W. Sleasman, and M.M. Goodenow Natural variation in HIV-1 protease, gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by Human Immunodeficiency Virus Type 1 Virology 219 1996 407 416
5. A. Cimarelli, and J.-L. Darlix Biomedicine and diseases: review. Assembling the human immunodeficiency virus type 1 Cell Mol. Sci. 59 2002 1166 1184
6. D.G. Demirov, J.M. Orenstein, and E.O. Freed The late domain of Human Immunodeficiency Virus Type 1 p6 promotes virus release in a cell type-dependent manner J. Virol. 2002 76105 76117
7. R.C. Desrosiers, J.D. Lifson, J.S. Gibbs, S.C. Czajak, A.Y.M. Howe, L.O. Arthur, and R.P. Johnson Identification of highly attenuated mutants of Simian Immunodeficiency Virus J. Virol. 72 1998 1431 1437
8. E.O. Freed Viral late domains J. Virol. 76 2002 4679 4687
9. J.E. Garrus, U.K. von Schwedler, O.W. Pornillos, S.G. Morham, K.H. Zavitz, H.E. Wang, D.A. Wettstein, K.M. Stray, M. Cote, R.L. Rich, D.G. Myszka, and W.I. Sundquist Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding Cell 107 2001 55 65
10. J.S. Gibbs, D.A. Regier, and R.C. Desrosiers Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes AIDS Res. Hum. Retroviruses 10 1994 333 342
11. S.N. Ho, H.D. Hunt, R.M. Horton, J.K. Pullen, and L.R. Pease Site-directed mutagenesis by overlap extension using the polymerase chain reaction Gene 77 1989 51 59
12. M. Huang, J.M. Orenstein, M.A. Martin, and E.O. Freed p6gag is required for particle production from full-length Human Immunodeficiency Virus Type 1 molecular clones expressing protease J. Virol. 69 1995 6810 6818
13. T.M. Jacks, M.D. Power, F.R. Masiarz, P.A. Luciw, P.J. Barr, and H.E. Varmus Characterization of ribosomal frameshifting in HIV-1 gag-pol expression Nature 331 1988 280 283
14. W.E. Johnson, J.M. Sauvron, and R.C. Desrosiers Conserved, N-linked carbohydrates of human immunodeficiency virus type 1 gp41 are largely dispensable for viral replication J. Virol. 75 2001 11426 11436
15. W.E. Johnson, J. Morgan, J. Reitter, B.A. Puffer, S.C. Czajak, R.W. Doms, and R.C. Desrosiers A replication-competent, neutralization-sensitive variant of simian immunodeficiency virus lacking 100 amino acids of envelope J. Virol. 76 2002 2075 2086
16. W.E. Johnson, J.D. Lifson, S.M. Lang, R.P. Johnson, and R.C. Desrosiers Importance of B-cell responses for immunological control of variant strains of simian immunodeficiency virus J. Virol. 77 2003 375 381
17. E. Kondo, and H.G. Gottlinger A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of Human Immunodeficiency Virus Type 1 vpr J. Virol. 70 1996 159 164
18. J.M. Louis, G.M. Clore, and A.M. Gronenborn Autoprocessing of HIV-1 protease is tightly coupled to protein folding Nat. Struct. Biol. 6 1999 868 875
19. Y. Lu, R.P. Bennett, J.W. Wills, R. Gorelick, and L. Ratner A leucine triplet repeat sequence (LXX)4 in p6gag is important for vpr incorporation into Human Immunodeficiency Virus Type 1 particles J. Virol. 69 1995 6873 6879
20. J. Martin-Serrano, and P.D. Bieniasz A bipartite late-budding domain in human immunodeficiency virus type 1 J. Virol. 77 2003 12373 12377
21. R.E. Means, T.C. Greenough, and R.C. Desrosiers Neutralization sensitivity of cell culture-passaged Simian Immunodeficiency Virus J. Virol. 71 1997 7895 7902
22. L.J. Parent, R.P. Bennett, R.C. Craven, T.D. Nelle, N.K. Krishna, J.B. Bowzard, C.B. Wilson, B.A. Puffer, R.C. Montelaro, and J.W. Wills Positionally independent and exchangeable late budding functions of the Rous Sarcoma Virus and Human Immunodeficiency Virus gag proteins J. Virol. 69 1995 5455 5460
23. K. Partin, G. Zybarth, L. Ehrlich, M. DeCrombrugghe, E. Wimmer, and C. Carter Deletion of sequences upstream of the proteinase improves the proteolytic processing of human immunodeficiency virus type 1 Proc. Natl. Acad. Sci. U.S.A. 1991 884776 884780
24. C. Paulus, S. Hellebrand, U. Tessmer, H. Wolf, H. Krausslich, and R. Wagner Competitive inhibition of Human Immunodeficiency Virus Type-1 protease by the gag-pol transframe protein J. Biol. Chem. 274 1999 21539 21543
25. S. Peters, M. Munoz, S. Yerly, V. Sanchea-Merino, C. Lopez-Galindez, L. Perrin, B. Larder, D.C. Cmarko, S. Fakan, P. Meylan, and A. Telenti Resistance to nucleoside analog reverse transcriptase inhibitors mediated by Human Immunodeficiency Virus Type 1 p6 protein J. Virol. 75 2001 9644 9653
26. O.W. Pornillos, S.L. Alam, D.R. Davis, and W.I. Sundquist Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein Nat. Struct. Biol. 9 2002 812 817
27. L. Selig, J.-C. Pages, V. Tanchou, S. Preveral, C. Berlioz-Torrent, L.X. Liu, L. Erdtmann, J.-L. Darlix, R. Benarous, and S. Benichou Interaction with the p6 domain of the gag precursor mediates incorporation into virions of vpr and vpx proteins from primate lentiviruses J. Virol. 73 1999 592 600
28. B.A. Strack, A. Calistri, S. Craig, E. Popova, and H.G. Gottlinger AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding Cell 114 2003 1 20
29. L. Verplank, F. Bouamr, T.J. LaGrassa, B. Agresta, A. Kikonyogo, J. Leis, and C.A. Carter Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag Proc. Natl. Acad. Sci. U.S.A. 98 2001 7724 7729